Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.
Hay, Kevin A
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies. [electronic resource] - Drugs Mar 2017 - 237-245 p. digital
Publication Type: Journal Article; Review
1179-1950
10.1007/s40265-017-0690-8 doi
Antigens, CD19--immunology
Humans
Immunotherapy
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Receptors, Antigen, T-Cell--immunology
T-Lymphocytes--immunology
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies. [electronic resource] - Drugs Mar 2017 - 237-245 p. digital
Publication Type: Journal Article; Review
1179-1950
10.1007/s40265-017-0690-8 doi
Antigens, CD19--immunology
Humans
Immunotherapy
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Receptors, Antigen, T-Cell--immunology
T-Lymphocytes--immunology